(Q34234670)

31 July 2017

title

Epigenetic subclassification of meningiomas based on genome-wide DNA methylation analyses (English)

1 reference

31 July 2017

0 references

Toshihiko Wakabayashi

12

object named as

Toshihiko Wakabayashi

1 reference

31 July 2017

2

Atsushi Natsume

1 reference

31 July 2017

8

Kiyoshi Saito

1 reference

31 July 2017

9

Hitoshi Ando

1 reference

31 July 2017

Yugo Kishida

1

1 reference

31 July 2017

Yutaka Kondo

3

1 reference

31 July 2017

Ichiro Takeuchi

4

1 reference

31 July 2017

Byonggu An

5

1 reference

31 July 2017

Yasuyuki Okamoto

6

1 reference

31 July 2017

Keiko Shinjo

7

1 reference

31 July 2017

Fumiharu Ohka

10

1 reference

31 July 2017

Yoshitaka Sekido

11

1 reference

31 July 2017

language of work or name

English

0 references

publication date

18 November 2011

1 reference

31 July 2017

1 reference

31 July 2017

volume

33

1 reference

31 July 2017

issue

2

1 reference

31 July 2017

page(s)

436-441

1 reference

Classic, atypical, and anaplastic meningioma: three histopathological subtypes of clinical relevance.

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR260

Meningioma grading: an analysis of histologic parameters.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR260

Long-term recurrence rates of atypical meningiomas after gross total resection with or without postoperative adjuvant radiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR260

The accuracy of meningioma grading: a 10-year retrospective audit

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR260

S100A5: a marker of recurrence in WHO grade I meningiomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR260

Integrative genomic analysis identifies NDRG2 as a candidate tumor suppressor gene frequently inactivated in clinically aggressive meningioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR260

Loss of tumor suppressor in lung cancer-1 (TSLC1) expression in meningioma correlates with increased malignancy grade and reduced patient survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR260

Inactivation patterns of NF2 and DAL-1/4.1B (EPB41L3) in sporadic meningioma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR260

The epigenomics of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR260

Hypermethylation and transcriptional downregulation of the TIMP3 gene is associated with allelic loss on 22q12.3 and malignancy in meningiomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR260

REporting recommendations for tumour MARKer prognostic studies (REMARK)

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR260

Variable DNA methylation patterns associated with progression of disease in hepatocellular carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR260

Epigenetic profiles distinguish malignant pleural mesothelioma from lung adenocarcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR260

Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR260

MGMT promoter methylation and field defect in sporadic colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR260

Integrated genetic and epigenetic analysis identifies three different subclasses of colon cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR260

Maternally expressed gene 3, an imprinted noncoding RNA gene, is associated with meningioma pathogenesis and progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR260

uPA/PAI-1 expression and uPA promoter methylation in meningiomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR260

CpG island methylator phenotype in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR260

Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR260

Hox genes: a continuation of embryonic patterning?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR260

Control of developmental regulators by Polycomb in human embryonic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR260

Epigenetic regulation of Hox gene activation: the waltz of methyls

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR260

Inactivation of HOXA genes by hypermethylation in myeloid and lymphoid malignancy is frequent and associated with poor prognosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR260

DNA methylation profiling of ovarian carcinomas and their in vitro models identifies HOXA9, HOXB5, SCGB3A1, and CRABP1 as novel targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR260

Homeobox gene methylation in lung cancer studied by genome-wide analysis with a microarray-based methylated CpG island recovery assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR260

Identification of methylated genes associated with aggressive clinicopathological features in mantle cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR260

Detection of bladder cancer using novel DNA methylation biomarkers in urine sediments

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR260

Distinct profiles of epigenetic evolution between colorectal cancers with and without metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR260

CRD-BP/IMP1 expression characterizes cord blood CD34+ stem cells and affects c-myc and IGF-II expression in MCF-7 cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR260

Targeted knockdown of the RNA-binding protein CRD-BP promotes cell proliferation via an insulin-like growth factor II-dependent pathway in human K562 leukemia cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR260

Blocking beta-catenin binding to the ZBP1 promoter represses ZBP1 expression, leading to increased proliferation and migration of metastatic breast-cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGR260

21 January 2018

Identifiers

DOI

10.1093/CARCIN/BGR260

1 reference

31 July 2017

1 reference